We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Illumina Inc | NASDAQ:ILMN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.71 | -4.61% | 118.28 | 14.50 | 134.52 | 127.745 | 117.67 | 127.08 | 2,987,106 | 05:00:10 |
From May 2019 to May 2024
Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at the Cowen and Company 37th Annual Health Care Conference in Boston, Massachusetts on March 7, 2017. The live webcast is scheduled to begin at 10:00 AM ET and will feature a brief overview of the company by Marc Stapley, Executive Vice President and Chief Administrative Officer, followed by a question and answer session.
The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170221005481/en/
Illumina, Inc.Investors:Rebecca Chambers, 858-255-5243ir@illumina.comorMedia:Eric Endicott, 858-882-6822pr@illumina.com
1 Year Illumina Chart |
1 Month Illumina Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
